| Price | 10.97 |
| Price Change Today | +$0.02 (+0.18%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $10.95 |
| Previous Close | $10.95 |
| Daily Range | $10.95 - $10.97 |
| 52-Week Range | $4.13 - $10.99 |
| Volume | 1,645,814 |
| Micromet, Inc. is a biopharmaceutical company with a focus on the development of novel, proprietary antibody-based products for cancer and inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. Micromet has established a drug development platform based on its BiTE? technology, a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Micromet has established collaborations with MedImmune, Inc. and Serono. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment